Position in ANNX
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$6,902,512
+$5,009,451 QoQ
Shares Held
1,245,941
+230.4% QoQ
Ownership
0.624%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
19 quarters on record
Voting authority
Sole 81.51637998910061.ToString("F0")%
Shared 0.ToString("F0")%
None 18.483620010899394.ToString("F0")%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Derivatives in ANNX
reported options exposure · as of Mar 31, 2026CallValue
$277,000
CallShares
50,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. ANNX ranks #121 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in ANNX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,902,512 | 1,245,941 | Shares | Defined | 2026-05-05 | |
| 2026-03-31 | $277,000 | 50,000 | Call | Defined | 2026-05-05 | |
| 2025-12-31 | $1,893,061 | 377,104 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $1,055,723 | 346,139 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $780,292 | 325,122 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $515,979 | 267,348 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,686,338 | 328,721 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,297,231 | 219,127 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $370,307 | 75,573 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $652,799 | 91,046 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $225,120 | 49,586 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $58,171 | 24,649 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $94,797 | 26,931 | Shares | Sole | 2023-08-11 | |
| 2022-12-31 | $21,197 | 4,100 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $17,860 | 2,890 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $337,429 | 89,504 | Shares | Sole | 2022-08-10 | |
| 2021-12-31 | $622,137 | 54,146 | Shares | Sole | 2022-02-14 | |
| 2021-03-31 | $10,133 | 364 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $219,438 | 8,767 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $11,306 | 374 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||